A series of new monomers of 2,5-bis[(4-tertbutyl-phenyl)-1,3,4-oxadiazole] styrene (M-Ct) and
2,5-bis[(4-alkoxy-phenyl)-1,3,4-oxadiazole]styrene (M−OCm, m is the number of the carbons in the alkoxy groups,
m = 8, 10, 12, 14) were synthesized. Conventional radical polymerization of the monomers resulted in a series
of new mesogen-jacketed liquid crystalline polymer (MJLCP) containing the 1,3,4-oxadiazole unit. The chemical
structures of the monomers were confirmed by elemental analysis, mass spectrometry, 1H NMR, and IR. The
molecular characterization of the corresponding polymers of P-Ct and P-OCms was performed with 1H NMR,
gel permeation chromatography, and thermogravimetric analysis. Their phase structures and transitions were
investigated by differential scanning calorimetry, wide-angle X-ray diffraction, and polarized light microscopy
experiments. The P-Ct formed the hexatic columnar nematic (ΦHN) phase that is typical for MJLCPs, wherein
the chain molecules were rodlike. The P-OCms exhibited a well-defined smectic A (SA) phase. As the mesogenic
group is laterally jacketed to the polyethylene backbone through a single carbon−carbon bond, the P-OCm molecule
in the SA phase should be more or less ribbonlike with the backbone squeezed by the parallel aligned side chains
on both sides. The transition of the four P-OCms follows the sequence of SA ↔ N ↔ I. The comparison between
P-Ct and P-OCms indicates that the flexibility of the side-chain tails is crucial to determine the LC structures.
Namely, simply changing the chemical structures of small portion of the MJLCP may greatly vary the molecular
packing behavior and thus the molecular shape in LC phase structures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.